Physical interaction between neurofibromin and serotonin 5-HT 6 receptor promotes receptor constitutive activity
- 10 October 2016
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 113 (43), 12310-12315
- https://doi.org/10.1073/pnas.1600914113
Abstract
Active G protein-coupled receptor (GPCR) conformations not only are promoted by agonists but also occur in their absence, leading to constitutive activity. Association of GPCRs with intracellular protein partners might be one of the mechanisms underlying GPCR constitutive activity. Here, we show that serotonin 5 hydroxytryptamine 6 (5-HT6) receptor constitutively activates the Gs/adenylyl cyclase pathway in various cell types, including neurons. Constitutive activity is strongly reduced by silencing expression of the Ras-GTPase activating protein (Ras-GAP) neurofibromin, a 5-HT6 receptor partner. Neurofibromin is a multidomain protein encoded by the NF1 gene, the mutation of which causes Neurofibromatosis type 1 (NF1), a genetic disorder characterized by multiple benign and malignant nervous system tumors and cognitive deficits. Disrupting association of 5-HT6 receptor with neurofibromin Pleckstrin Homology (PH) domain also inhibits receptor constitutive activity, and PH domain expression rescues 5-HT6 receptor-operated cAMP signaling in neurofibromin-deficient cells. Furthermore, PH domains carrying mutations identified in NF1 patients that prevent interaction with the 5-HT6 receptor fail to rescue receptor constitutive activity in neurofibromin-depleted cells. Further supporting a role of neurofibromin in agonist-independent Gs signaling elicited by native receptors, the phosphorylation of cAMP-responsive element-binding protein (CREB) is strongly decreased in prefrontal cortex of Nf1+/− mice compared with WT mice. Moreover, systemic administration of a 5-HT6 receptor inverse agonist reduces CREB phosphorylation in prefrontal cortex of WT mice but not Nf1+/− mice. Collectively, these findings suggest that disrupting 5-HT6 receptor–neurofibromin interaction prevents agonist-independent 5-HT6 receptor-operated cAMP signaling in prefrontal cortex, an effect that might underlie neuronal abnormalities in NF1 patients.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-BLAN-SVSE4-LS-110627)
This publication has 37 references indexed in Scilit:
- Genetic and Functional Studies Implicate Synaptic Overgrowth and Ring Gland cAMP/PKA Signaling Defects in the Drosophila melanogaster Neurofibromatosis-1 Growth DeficiencyPLoS Genetics, 2013
- Nf1 RasGAP Inhibition of LIMK2 Mediates a New Cross-Talk between Ras and Rho PathwaysPLOS ONE, 2012
- Neurofibromatosis Type 1: Modeling CNS DysfunctionJournal of Neuroscience, 2012
- 5‐HT 6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophreniaEMBO Molecular Medicine, 2012
- The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEBMolecular Brain, 2012
- Influence of social isolation in the rat on serotonergic function and memory – Relevance to models of schizophrenia and the role of 5-HT6 receptorsNeuropharmacology, 2011
- Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent mannerProceedings of the National Academy of Sciences of the United States of America, 2011
- Physical Interaction of Jab1 with Human Serotonin 6 G-protein-coupled Receptor and Their Possible Roles in Cell SurvivalPublished by Elsevier BV ,2010
- Neurofibromin Regulation of ERK Signaling Modulates GABA Release and LearningCell, 2008
- A Novel Rat Serotonin (5-HT6) Receptor: Molecular Cloning, Localization and Stimulation of cAMP AccumulationBiochemical and Biophysical Research Communications, 1993